Latest Biotech News

Gladstone Institutes and UCSF reported a genome-wide CRISPR map of human genes that promote or restrict HIV infection in primary CD4+ T cells. Published in Cell, the work provides a host–virus...

UCL and UCLH reported follow-up results from the NEOPRISM-CRC trial testing a short course of immunotherapy before surgery for a subset of bowel cancer patients. The update highlighted zero...

Nomic Bio partnered with Broad Clinical Labs to integrate Nomic’s Nomic Omni 1000 immunoassay platform into BCL’s omics offerings. The collaboration is intended to combine broad protein...

10x Genomics launched Atera at AACR, positioning the in situ spatial biology platform for whole-transcriptome analysis at high throughput. The company said Atera can image multiple slides per run,...

Nektar reported Phase II extension results for rezpegaldesleukin (rezpeg) in severe alopecia areata, describing additional hair regrowth in patients continuing treatment. The update focused on...

Ultima Genomics reported TRACERx trial data supporting a whole-genome ctDNA approach using duplex sequencing without bespoke tumor-informed assays. At AACR, Jonathan Wan of UCL and the Francis...

Researchers reported in Nature Communications that JAK1 inhibitors reduce ulcerative colitis activity through suppression of the NLRP3–IL-1β signaling axis. The mechanistic work links a widely...

Industry reporting detailed how Lilly’s Kelonia acquisition fits a broader “in vivo” genetic medicines strategy, building on prior deals to expand the company’s cell therapy and genetic medicine...

Eli Lilly agreed to acquire Kelonia Therapeutics in a deal worth up to $7 billion, expanding the company’s in vivo CAR-T ambitions for multiple myeloma and beyond. Lilly will pay $3.25 billion...

Nektar Therapeutics disclosed additional hair-regrowth data from a 16-week extension of its Phase IIb REZOLVE-AA study of rezpegaldesleukin (rezpeg), highlighting deeper responses among late...

At AACR, researchers reported clinical value for tumor-informed MRD detection using whole-genome sequencing paired with Ultima Genomics duplex sequencing in TRACERx. The approach, using paired...

A clinical trial led by University College London (UCL) and UCL Hospitals (UCLH) reported follow-up results from NEOPRISM-CRC, testing a short course of immunotherapy prior to surgery for a subset...

Gladstone Institutes and UCSF published a genome-wide CRISPR screen mapping human genes that either promote or restrict HIV infection in primary CD4+ T cells. Using optimized infection conditions...

Researchers developed an AI model to predict how proteins behave by reading and learning patterns from protein pairs, targeting better representation of protein–protein interactions. The platform...

10x Genomics launched Atera, an in situ spatial biology platform aimed at whole-transcriptome profiling with single-cell resolution and higher throughput. The company said the instrument will...

Roche’s affiliate Foundation Medicine agreed to acquire SAGA Diagnostics in a transaction valued at up to $595 million, designed to broaden Foundation’s MRD diagnostics portfolio. The deal adds...

The FDA published a perspective on eliminating unnecessary animal studies, pushing developers toward more scientifically justified nonclinical packages and away from redundant preclinical work....

Nomic Bio partnered with Broad Clinical Labs (BCL) to integrate Nomic’s Nomic Omni 1000 immunoassay platform into BCL’s omics offerings. The collaboration is intended to incorporate quantitative...

Eli Lilly announced it will acquire Kelonia Therapeutics for up to $7 billion, paying $3.25 billion upfront with additional milestone payments tied to clinical, regulatory and commercial outcomes....

Further coverage of the acquisition highlights how Kelonia’s in vivo gene placement system (iGPS) adds another clinical-stage asset to Lilly’s genetic medicines roadmap. The buyer’s broader...